Mupirocin  (PDF Version)

 

Antibiotic Class:

Monoxycarbolic acid

 

Antimicrobial Spectrum:

Streptococcus spp., Staphylococcus spp., H. influenzae, M. catarrhalis, Neisseria spp., P. multocida

 

Mechanism of Action:

Protein synthesis interruption by inhibition of isoleucine incorporation into growing bacterial protein chain.

 

Pharmacodynamics:

No data

 

Pharmacokinetics:

Protein binding: 95%

Serum half-life: 20-35 minutes

 

Adverse Effects:

Nares: local irritation, rhinitis

Skin: Rash, purities, headache

Other: taste alterations

 

Dosage:

Mupirocin Nasal Ointment (Parafin based) (1g)

Mupirocin Ointment (15, 30g)

Muprocin Ointment (Polyethylene glycol based) (22g)

 

Impetigo: Apply to affected area q 8 hours for 3 to 5 days

Nasal decolonization of MRSA: Apply to nares q 12h for 5 days

 

Disease state based dosing:

Renal failure:  Dosing adjustments not necessary

Hepatic failure:  Dosing adjustments not necessary

 

Contraindications/Warnings/Precautions:

Precautions:

 

Drug Interactions:

No data available

 

Pregnancy:

Category B: No evidence of risk in humans but studies inadequate.

 

Monitoring requirements:

Patients should be monitored for symptoms of local irritation.

No laboratory parameters exist to monitor for efficacy or toxicity

 

Brand names/Manufacturer: